ACIU · AC Immune SA
Market Cap
$282.37M
Shares
99.43M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-03 | — | |
| 6-K | 2026-08-20 | — | |
| 6-K | 2026-08-11 | — | |
| 6-K | 2026-08-05 | 2026-06-30 | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-11 | — | |
| 6-K | 2026-06-11 | — | |
| 6-K | 2026-05-15 | — | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-04-30 | — | |
| 6-K | 2026-04-30 | — | |
| 6-K | 2026-04-07 | 2026-04-02 | |
| 6-K | 2026-03-13 | — | |
| 20-F | 2026-03-13 | 2025-12-31 | |
| 6-K | 2026-02-24 | — | |
| 6-K | 2026-02-17 | — | |
| 6-K | 2025-12-11 | — | |
| 6-K | 2025-11-04 | — | |
| 6-K | 2025-09-04 | — | |
| 6-K | 2025-08-05 | 2025-06-30 | |
| 6-K | 2025-06-20 | — | |
| 6-K | 2025-06-11 | — | |
| 6-K | 2025-05-19 | — | |
| 6-K | 2025-04-30 | — | |
| 6-K | 2025-03-13 | — | |
| 20-F | 2025-03-13 | 2024-12-31 | |
| 6-K | 2024-12-18 | — | |
| 6-K | 2024-12-10 | — | |
| 6-K | 2024-11-14 | — | |
| 6-K | 2024-11-05 | — | |
| 6-K | 2024-09-19 | — | |
| 6-K | 2024-09-17 | — | |
| 6-K | 2024-08-28 | — | |
| 6-K | 2024-08-06 | 2024-06-30 | |
| 6-K | 2024-08-06 | — | |
| 6-K | 2024-07-31 | — | |
| 6-K | 2024-07-25 | — | |
| 6-K | 2024-06-20 | — | |
| 6-K | 2024-05-21 | — | |
| 6-K | 2024-05-13 | — | |
| 6-K | 2024-05-13 | — | |
| 6-K | 2024-03-14 | — | |
| 20-F | 2024-03-14 | 2023-12-31 | |
| 6-K | 2024-01-22 | — | |
| 6-K | 2024-01-03 | — | |
| 6-K | 2023-12-19 | — | |
| 6-K | 2023-12-15 | 2023-12-14 | |
| 6-K | 2023-12-01 | — | |
| 6-K | 2023-11-03 | — | |
| 6-K | 2023-08-04 | 2023-06-30 |
Showing 1–50 of 105 filings
Key facts
CIK
1651625
CUSIP
H00263105
13F (30d)
36 filings
36 filers
Visit website
Investor relations